HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postnatal development of flash visual evoked potentials in the jaundiced Gunn rat.

Abstract
In this study, the postnatal development of flash visual evoked potential (VEP) has been monitored in the jaundiced (jj) Gunn rat model of neonatal hyperbilirubinemia to determine whether this evoked response is affected by bilirubin-induced neurotoxicity. VEP could first be recorded at 16 d of age. The jj rats exhibited prolonged wave latencies and lower wave amplitudes during the 3rd wk of postnatal life, when compared with their nonjaundiced littermates. There was no correlation at 21 d of age between VEP parameters and either bilirubin levels or body weight. About one third of the jj animals died between 21 and 28 d of age. The average VEP wave latencies at 21 d of age of the rats who were to die was prolonged compared with those of rats who survived till at least 28 d of age. Thus, the latency of VEP waves at the age of 21 d appears to be related to the further outcome of jj Gunn rats. Although wave amplitudes were lower in jj as compared with nonjaundiced 21-d-old animals, there were no amplitude differences between the jj rats who would die and those who would survive during the 4th wk of life. These findings may contribute to the understanding of the pathogenesis of bilirubin encephalopathy in the neonatal period.
AuthorsS Silver, J Kapitulnik, H Sohmer
JournalPediatric research (Pediatr Res) Vol. 30 Issue 5 Pg. 469-72 (Nov 1991) ISSN: 0031-3998 [Print] United States
PMID1754303 (Publication Type: Journal Article)
Topics
  • Age Factors
  • Animals
  • Animals, Newborn
  • Evoked Potentials, Visual
  • Female
  • Hyperbilirubinemia (physiopathology)
  • Jaundice (physiopathology)
  • Photic Stimulation
  • Pregnancy
  • Rats
  • Rats, Gunn
  • Visual Pathways (growth & development, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: